Biometric Update: Data on Fingerprint Drug Screening Pilot

Biometric Update Data on Fingerprint Drug Screening Pilot

Originally published by Biometric Update.

Intelligent Fingerprinting Presents Data on Fingerprint Drug Screening Pilot

Intelligent Fingerprinting recently presented evaluation data from its pilot project testing the potential use of its new mobile drug-screening device by coroners and mortuary staff to collect early intelligence on the cause of death.

The firm, which presented the preliminary results at the Coroner’s Society of England and Wales Annual Conference, is now discussing the possibility of extending the Innovate UK-funded pilot to a wider customer trial.

Conducted by Intelligent Fingerprinting and the Sheffield Legal-Medico Centre, the trial is validating a new non-invasive drug screening technique that could help coroners prioritise when costly post-mortems are necessary and enable earlier release of the deceased for burial.

Intelligent Fingerprinting’s drug screening device collects and analyses sweat from an individual’s fingerprint to provide data on recent drug use, achieving results in under ten minutes.

Coroners could potentially use the technology to gain early intelligence on the drug use of the deceased.

“It has been fascinating to watch this technology being developed stage by stage,” said Christopher Dorries, HM Coroner South Yorkshire West Area. “Although we are at an early stage of comparing results with the nearly finished product, the testing so far has suggested that this will be a really useful tool for bed-side toxicology indication, albeit not intended to be evidential. It should alert us to the cases that need to be subject to full toxicology, and in some cases, may obviate the need for any toxicology tests at all.”

With the relatives’ consent, Intelligent Fingerprinting researchers collected and tested 180 fingerprint sweat samples from the Sheffield mortuary in its laboratory for the presence of opiates.

The fingertip sweat samples represented a wide range of categories of death and body preservation.

Using Intelligent Fingerprinting’s technology, the researchers achieved a correlation of over 90% between the samples they analysed and post-mortem toxicology results.

As part of the pilot, the samples are now being tested in real time in the mortuary using the firm’s portable drug-screening device.

The first results show a similar correlation to conventional post-mortem toxicology results for opiates and cocaine.

“This new non-invasive technology has the potential to provide early intelligence about drug use to help determine the likely cause of death and allow coroners to prioritise where a full post-mortem and laboratory toxicology tests are required, thereby saving costs,” said Dr Paul Yates from Intelligent Fingerprinting.

“The device could also quickly reveal the presence of drugs in cases which may otherwise have been overlooked as unsuspicious. We are very pleased by the enthusiasm shown by other coroners offering to help us build our data set by taking part in a wider trial of our device.”

Meet The Author

Intelligent Fingerprinting

Intelligent Fingerprinting

Related Articles

Fingerprint drug testing during procurement

Do contracts require a drug and alcohol policy? Increasingly, the answer is yes. For a few sectors it is a legal requirement; for many more it has become a commercial one, written into the pre-qualification questionnaires and supply-chain standards that decide who gets shortlisted. Either way, the direction of travel is the same: a documented…

Fingerprint drug testing cartridge

Is workplace drug testing worth it? A fair question. Most organisations weigh the cost of testing against zero: the price of the kits versus doing nothing at all. Counted that way, testing will always look like an expense to contain. But that sum measures only one side of the ledger. It ignores what a well-run…

The business case for workplace drug testing

Most workplace drug testing programmes are judged on a single question: How much does it cost? This white paper asks a better question: What does testing earn? What costs does it reduce? Written for finance, safety, human resources (HR), and operations leaders, this free white paper gives you the numbers. It shifts the conversation from…

Book A Demo

See the difference fingerprint drug testing can make in your workplace. Request a personalised demonstration today.